Clinical Trials Study
Copyright ©The Author(s) 2024.
World J Clin Cases. Aug 26, 2024; 12(24): 5523-5533
Published online Aug 26, 2024. doi: 10.12998/wjcc.v12.i24.5523
Table 2 Comparison of two groups before and after intervention
OutcomeA3 group
Control group
Baseline
2 wk
Baseline
2 wk
BADL67.14 ± 15.83686.43 ± 10.874a71.67 ± 10.56175.19 ± 9.556a
SSQOL156.36 ± 23.429178.93 ± 23.650a154.67 ± 17.236158.74 ± 17.295a
FM balance meter8.54 ± 0.9999.75 ± 1.456a8.52 ± 0.7008.70 ± 0.542a
FMA (lower limbs)20.07 ± 5.64323.57 ± 5.473a21.22 ± 5.82022.19 ± 6.032a
RMI8.75 ± 1.93610.82 ± 1.679a8.44 ± 1.2818.85 ± 1.460a
HWAS2.86 ± 0.7563.75 ± 0.585a2.81 ± 0.7362.93 ± 0.675b
TUG(s)32.404 ± 14.72620.029 ± 7.228a29.643 ± 12.34826.842 ± 9.600a
Stride frequency as step/min76.018 ± 19.97894.857 ± 17.678a86.093 ± 17.10089.889 ± 13.480b
Stride speed in cm/s45.643 ± 19.18790.768 ± 77.937a53.389 ± 23.00961.796 ± 21.825a
Stride length in cm70.054 ± 18.92199.500 ± 26.606a72.426 ± 24.72281.111 ± 22.263a
Lng1360.61 ± 774.611925.36 ± 408.597a1463.70 ± 1061.3821397.04 ± 948.131b
Area1889.64 ± 1334.954980.96 ± 728.462a2165.63 ± 1474.6661755.59 ± 987.181b
TL index0.901 ± 0.3611.352 ± 0.665a0.941 ± 08830.952 ± 0.499b